Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefiderocol and Ampicillin-sulbactam for CRAB Infections
NCT05922124Phase 4Recruiting
- Sponsor
- Rambam Health Care Campus
- Start
- Sep 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefiderocol in Acinetobacter baumannii infection, sponsored by Rambam Health Care Campus. Started Sep 2024; status: recruiting.
02
Drugs
cefiderocol
03
Conditions
Acinetobacter baumannii infection
Beyond the preview
Go deeper on NCT05922124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05922124.